Mirae Asset Global Investments Co. Ltd. Takes Position in iShares Biotechnology ETF $IBB

Mirae Asset Global Investments Co. Ltd. purchased a new position in iShares Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 195,308 shares of the financial services provider’s stock, valued at approximately $32,962,000.

Other large investors also recently modified their holdings of the company. Baxter Bros Inc. increased its position in shares of iShares Biotechnology ETF by 10.1% in the fourth quarter. Baxter Bros Inc. now owns 2,612 shares of the financial services provider’s stock worth $441,000 after purchasing an additional 240 shares during the last quarter. Nations Financial Group Inc. IA ADV lifted its position in iShares Biotechnology ETF by 107.0% during the fourth quarter. Nations Financial Group Inc. IA ADV now owns 5,010 shares of the financial services provider’s stock valued at $846,000 after purchasing an additional 2,590 shares during the last quarter. Cornerstone Wealth Group LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter valued at approximately $205,000. WorthPointe LLC purchased a new position in iShares Biotechnology ETF in the 4th quarter worth approximately $1,424,000. Finally, Massachusetts Wealth Management grew its stake in iShares Biotechnology ETF by 23.4% in the 4th quarter. Massachusetts Wealth Management now owns 4,015 shares of the financial services provider’s stock worth $678,000 after buying an additional 762 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB opened at $176.66 on Friday. The company’s fifty day moving average price is $170.28 and its 200-day moving average price is $167.10. iShares Biotechnology ETF has a one year low of $116.25 and a one year high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were paid a $0.1218 dividend. This represents a $0.49 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend was Tuesday, March 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.